Works matching AU Dong Won Park


Results: 64
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Clinical characteristics of rheumatoid arthritis patients with interstitial lung disease: baseline data of a single-center prospective cohort.

    Published in:
    Arthritis Research & Therapy, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13075-023-03024-8
    By:
    • Kim, Hyoungyoung;
    • Cho, Soo-Kyung;
    • Song, Yeo-Jin;
    • Kang, Juyeon;
    • Jeong, Seung-A;
    • Kim, Hye Won;
    • Choi, Chan-Bum;
    • Kim, Tae-Hwan;
    • Jun, Jae-Bum;
    • Bae, Sang-Cheol;
    • Yoo, Dae-Hyun;
    • Lee, Hyun;
    • Park, Dong Won;
    • Sohn, Jang Won;
    • Yoon, Ho Joo;
    • Hong, Su Jin;
    • Yoo, Seung-Jin;
    • Choi, Yo Won;
    • Lee, Youkyung;
    • Kim, Sang Heon
    Publication type:
    Article
    17
    18
    19
    20
    21

    Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR Mutation.

    Published in:
    Clinical Respiratory Journal, 2025, v. 19, n. 1, p. 1, doi. 10.1111/crj.70043
    By:
    • Yeo, Chang Dong;
    • Park, Dong Won;
    • Yoon, Seong Hoon;
    • Kim, Eun Young;
    • Lee, Jeong Eun;
    • Lee, Shin Yup;
    • Choi, Chang‐Min;
    • Oh, In‐Jae;
    • Kim, Do Jin;
    • Ryu, Jeong Seon;
    • Lee, Jae Cheol;
    • Kim, Young‐Chul;
    • Jang, Tae Won;
    • Lee, Kye Young;
    • Jang, Seung Hun;
    • Kim, Seung Joon;
    • Kim, Chi Young;
    • Kim, In Ae;
    • Son, Ji Woong;
    • Lee, Seung Hyeun
    Publication type:
    Article
    22
    23
    24
    25

    Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity.

    Published in:
    Experimental & Molecular Medicine EMM, 2024, v. 56, n. 3, p. 570, doi. 10.1038/s12276-024-01172-8
    By:
    • Yoon, Jihoon G.;
    • Jang, Dong Geon;
    • Cho, Sung-Gyu;
    • Lee, Chaeyoung;
    • Noh, Shin Hye;
    • Seo, Soo Kyung;
    • Yu, Jung Woo;
    • Chung, Hyeon Woo;
    • Han, KyeoRe;
    • Kwon, Soon Sung;
    • Han, Dai Hoon;
    • Oh, Jaeseong;
    • Jang, In-Jin;
    • Kim, Sang-Hoon;
    • Jee, Young-Koo;
    • Lee, Hyun;
    • Park, Dong Won;
    • Sohn, Jang Won;
    • Yoon, Ho Joo;
    • Kim, Chul Hoon
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation‐positive non‐small cell lung cancer (stage III) who have not progressed following definitive, platinum‐based, chemoradiation therapy (PLATINUM trial)

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 23, p. 3431, doi. 10.1111/1759-7714.14663
    By:
    • Choi, Juwhan;
    • Lee, Jeong Eun;
    • Choi, Chang‐Min;
    • Oh, In‐Jae;
    • Lee, Kye Young;
    • Jang, Tae Won;
    • Lee, Seung Hyeun;
    • Kim, Eun Young;
    • Park, Dong Won;
    • Park, Sun Hyo;
    • Lee, Sung Yong
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50